{
  "abstract": "Colitis is a form of inflammatory bowel disease characterized by chronic inflammation of the colon. In this study, we investigated the therapeutic potential of Δ8-tetrahydrocannabinol (Δ8-THC), a cannabinoid with lower psychoactive potency than the well-characterized Δ9-THC, in murine models of colitis. Colitis was induced with dextran sulfate sodium (DSS) in C57BL/6J mice or 2,4,6-trinitrobenzenesulfonic acid (TNBS) in BALB/c mice, and Δ8-THC was administered intraperitoneally at 20 mg/kg. Treatment with Δ8-THC significantly attenuated disease severity, as evidenced by improved colonoscopic findings and restoration of colon length. At the cellular level, Δ8-THC reduced the infiltration of myeloid cells and shifted macrophage polarization from a pro-inflammatory M1 phenotype toward an anti-inflammatory M2 phenotype. Exploratory miRNA sequencing in colonic samples identified alterations in regulatory miRNAs, with mmu-let-7a-5p emerging as a key candidate. Differential expression of let-7a-5p was validated by qPCR. In the RAW 264.7 macrophage cell line, mimic and inhibitor experiments showed that manipulation of let-7a-5p modulated Cd86 transcript levels. Computational analyses predicted a potential let-7a-5p–Cd86 interaction. Together, these findings demonstrate that Δ8-THC attenuates colitis, which is associated with increased let-7a-5p expression in the colon, and support a potential role for this miRNA in regulating macrophage-associated inflammatory responses.",
  "abstract_shown": true,
  "affiliations": [],
  "article_type": "Original Research",
  "arxiv": null,
  "author_total": 5,
  "authors": [
    {
      "name": "Jeffrey I. Garcia-Sanchez"
    },
    {
      "name": "Taylor H. Carter"
    },
    {
      "name": "Urmi Halder"
    },
    {
      "name": "Mitzi Nagarkatti"
    },
    {
      "name": "Prakash Nagarkatti"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/dvb32rat8ezn4.bib",
  "cited_by": 0,
  "doi": "10.3389/fphar.2026.1973874",
  "fulltext_url": null,
  "id": "dvb32rat8ezn4",
  "issns": [
    "1663-9812"
  ],
  "landing_url": "https://www.frontiersin.org/articles/10.3389/fphar.2026.1973874",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "feed-journal",
      "medicine/pharmacology-toxicology"
    ]
  ],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-13",
  "publisher": "Frontiers Media SA",
  "ris": "https://research.draconitic.com/paper/dvb32rat8ezn4.ris",
  "sources": [
    {
      "first_seen": "2026-11-13T18:20:15Z",
      "native_id": "10.3389/fphar.2026.1973874",
      "source": "feed-frontiers",
      "url": "https://www.frontiersin.org/articles/10.3389/fphar.2026.1973874"
    },
    {
      "first_seen": "2026-11-14T00:21:07Z",
      "native_id": "10.3389/fphar.2026.1973874",
      "source": "crossref",
      "url": "https://www.frontiersin.org/articles/10.3389/fphar.2026.1973874/full"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "feed-journal:medicine/pharmacology-toxicology",
      "subfield": "pharmacology-toxicology"
    }
  ],
  "title": "Delta-8-tetrahydrocannabinol attenuates colitis and is associated with changes in myeloid cell phenotypes and let-7a-5p expression",
  "title_text": "Delta-8-tetrahydrocannabinol attenuates colitis and is associated with changes in myeloid cell phenotypes and let-7a-5p expression",
  "type": "peer-reviewed",
  "updated_at": "2026-11-15T00:21:33Z",
  "url": "https://research.draconitic.com/paper/dvb32rat8ezn4",
  "venue": "Frontiers in Pharmacology",
  "versions": []
}